Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Carbocyclic inosine is a synthetic molecule that mimics the structure of inosine, a naturally occurring nucleoside found in RNA. The carbocyclic modification replaces the oxygen atom in the sugar ring of inosine with a carbon atom, making it more stable and resistant to degradation by enzymes in the body. This modification has the potential to enhance the therapeutic properties of inosine, such as its ability to modulate immune responses and protect against neurodegenerative diseases. Carbocyclic inosine is being investigated for its potential applications in pharmacology and medicine, with early studies showing promising results in animal models of inflammatory diseases and neurological disorders. Its unique structure and biological properties make it a promising candidate for the development of novel therapeutic agents.

16975-94-3 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 9-((1R,2S,3R,4R)-2,3-Dihydroxy-4-(hydroxymethyl)cyclopentyl)-1H-purin-6(9H)-one

    Cas No: 16975-94-3

  • USD $ 1.9-2.9 / Gram

  • 100 Gram

  • 1000 Metric Ton/Month

  • Chemlyte Solutions
  • Contact Supplier
  • 9-[(1R,2S,3R,4R)-2,3-dihydroxy-4-(hydroxymethyl)cyclopentyl]-3H-purin-6-one

    Cas No: 16975-94-3

  • No Data

  • No Data

  • No Data

  • BOC Sciences
  • Contact Supplier
  • 16975-94-3 Structure
  • Basic information

    1. Product Name: carbocyclic inosine
    2. Synonyms: carbocyclic inosine
    3. CAS NO:16975-94-3
    4. Molecular Formula: C11H14N4O4
    5. Molecular Weight: 266.25326
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 16975-94-3.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 640.4°C at 760 mmHg
    3. Flash Point: 341.1°C
    4. Appearance: /
    5. Density: 1.92g/cm3
    6. Vapor Pressure: 2.82E-17mmHg at 25°C
    7. Refractive Index: 1.856
    8. Storage Temp.: N/A
    9. Solubility: N/A
    10. CAS DataBase Reference: carbocyclic inosine(CAS DataBase Reference)
    11. NIST Chemistry Reference: carbocyclic inosine(16975-94-3)
    12. EPA Substance Registry System: carbocyclic inosine(16975-94-3)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 16975-94-3(Hazardous Substances Data)

16975-94-3 Usage

Uses

Used in Pharmacology and Medicine:
Carbocyclic inosine is used as a therapeutic agent for its potential to modulate immune responses and protect against neurodegenerative diseases. Its enhanced stability and resistance to degradation make it a promising candidate for the development of novel treatments for inflammatory diseases and neurological disorders.
Used in Drug Development:
Carbocyclic inosine is used as a lead compound in the development of new therapeutic agents. Its unique structure and biological properties offer opportunities for the creation of innovative drugs with improved efficacy and reduced side effects.
Used in Research:
Carbocyclic inosine is used as a research tool to study the mechanisms of action of inosine and its potential applications in various diseases. Early studies in animal models have shown promising results, providing valuable insights into the therapeutic potential of carbocyclic inosine and guiding future research and development efforts.

Check Digit Verification of cas no

The CAS Registry Mumber 16975-94-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,9,7 and 5 respectively; the second part has 2 digits, 9 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 16975-94:
(7*1)+(6*6)+(5*9)+(4*7)+(3*5)+(2*9)+(1*4)=153
153 % 10 = 3
So 16975-94-3 is a valid CAS Registry Number.
InChI:InChI=1/C11H14N4O4/c16-2-5-1-6(9(18)8(5)17)15-4-14-7-10(15)12-3-13-11(7)19/h3-6,8-9,16-18H,1-2H2,(H,12,13,19)

16975-94-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 19, 2017

Revision Date: Aug 19, 2017

1.Identification

1.1 GHS Product identifier

Product name 9-[2,3-dihydroxy-4-(hydroxymethyl)cyclopentyl]-3H-purin-6-one

1.2 Other means of identification

Product number -
Other names carbocyclic inosine

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16975-94-3 SDS

16975-94-3Downstream Products

16975-94-3Related news

carbocyclic inosine (cas 16975-94-3) as a potent anti-Leishmanial agent: The metabolism and selective cytotoxic effects of carbocyclic inosine (cas 16975-94-3) in promastigotes of Leishmania tropica08/05/2019

Carbocyclic inosine is a potent inhibitor for the growth of the promastigote form of Leishmania tropica and Leishmania donovani. In culture, the EC50 values of carbocyclic inosine are 8.3 × 10−8 and 1.3 × 10−7M for the promastigotes of L. tropica and L. donovani, respectively. On the other han...detailed

16975-94-3Relevant articles and documents

Conformationally restricted nucleosides. The reaction of adenosine deaminase with substrates built on a bicyclo[3.1.0]hexane template

Marquez, Victor E.,Russ, Pamela,Alonso, Randolph,Siddiqui, Maqbool A.,Shin, Kye-Jung,George, Clifford,Nicklaus, Marc C.,Dai, Fang,Ford Jr., Harry

, p. 521 - 530 (1999)

Adenosine deaminase (ADA) can discriminate between two distinct (North and South), conformationally rigid substrate conformers. (N)-methanocarba- 2'dA (4) is deaminated 100 times faster than the antipodal (S)-methanocarba- 2'dA (5), whereas a nonrigid analogue, aristeromycin (6), is deaminated at an intermediate rate. These results are in agreement with crystallographic data from ADA-ribonucleoside complexes showing the furanose ring of the bound purine in a C3'-endo (North) conformation. The data presented here suggests that 4 and 5 are useful probes to ascertain conformational preferences by purine metabolizing enzymes.

Synthesis of conformationally restricted carbocyclic nucleosides: The role of the O(4')-atom in the key hydration step of adenosine deaminase

Marquez, Victor E.,Russ, Pamela,Alonso, Randolph,Siddiqui, Maqbool A.,Hernandez, Susana,George, Clifford,Nicklaus, Marc C.,Dai, Fang,Ford Jr., Harry

, p. 2119 - 2129 (2007/10/03)

Conformationally restricted carbocyclic nucleosides with either a northern(N)-type conformation, i.e., N-type 2'-deoxy-methanocarba-adenosine 8 ((N)MCdAdo) or a southern(S)-type conformation, i.e. S-type 2'-deoxy- methanocarba-adenosine 9, ((S)MCdAdo), were used as substrates for adenosine deaminase (ADA) to assess the enzyme's preference for a fixed conformation relative to the flexible conformation represented by the carbocyclic nucleoside aristeromycin (10). Further comparison between the rates of deamination of these compounds with those of the two natural substrates adenosine (Ado: 1) and 2'-deoxyadenosine (dAdo; 2), as well as with that of the conformationally locked nucleoside LNA-Ado (11), which, like the natural substrates, has a furanose O(4') atom, helped differentiate between the roles of the O(4') anomeric effect and sugar conformation in controlling the rates of deamination by ADA. Differences in rates of deamination as large as 10000 can be attributed to the combined effect of the Q(4') atom and the enzyme's preference for an N-type conformation. The hypothesis proposed is that ADA's preference for N-type substrates is not arbitrary; it is rather the direct consequence of the conformationally dependent O(4') anomeric effect, which is more efficient in N-type conformers in promoting the formation of a covalent hydrate at the active site of the enzyme. The formation of a covalent hydrate at the active site of ADA precedes deamination. A new and efficient synthesis of the important carbobicyclic template 14a, a useful intermediate for the synthesis of (N)MCdAdo (8) and other conformationally restricted nucleosides is also reported.

Resolution of racemic carbocyclic analogues of purine nucleosides through the action of adenosine deaminase. Antiviral activity of the carbocyclic 2'-deoxyguanosine enantiomers

Secrist III.,Montgomery,Shealy,O'Dell,Clayton

, p. 746 - 749 (2007/10/02)

The action of adenosine deaminase on racemic carbocyclic analogues of 6-aminopurine nucleosides was investigated. When either racemic carbocyclic adenosine [(±)-C-Ado] or the racemic carbocyclic analogue [(±)-C-2,6-DAP-2'-dR] of 2,6-diaminopurine 2'-deoxyribofuranoside was incubated with this enzyme, approximately half of the material was deaminated rapidly. From the resulting solution, the D isomers of the deaminated carbocyclic analogues (D-carbocyclic inosine, D-C-Ino, or D-carbocyclic 2'-deoxyguanosine, D-2'-CDG) and the L isomers of the undeaminated carbocyclic analogues were isolated. At higher concentrations of the enzyme, deamination of (L)-C-Ado and (L)-C-2,6-DAP-2'dR proceeded slowly, thus also making the other enantiomers accessible. In tests in vitro against herpes simplex virus, types 1 and 2, D-2'-CDG was as active and potent as (±)-2'-CDG, whereas L-2'-CDG displayed only modest activity. In contrast to the previously reported high activity and potency of (±)-C-2,6-DAP-2'-dR against these two viruses, (L)-C-2,6-DAP-2'-dR was inactive.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16975-94-3